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To evaluate the e%ecl~ of late thmmbdpis on la% vent+ 
nlnr vdume and function in acufe myocardial infarc,ian, 
tw&bnes!onal efhoeardiography and radionuclide angi. 
ogmphy were prfomed b&a discharge and nRer I year 
of follou.up stutudy in 34 patients with acute anterior my* 
cardial infarctian. Gf thee, 10 admitted to the coronary 
can unit within 4 h fnnn the onset of symptoms were 
treated nith remmbtnant tisswtype plsriminogrn ci!va,or 
@t-PA) (Group A) and 24 admitted betwee 4 and 8 II atler 
enset were ramlamlv assiened to receive eilher r&PA 
(Group 8, n = 12) or~coov&o.td therapy (Gmup C’, n = 
1.2). Seven to IO days &er admission, all pa,ienlS under- 
wmt cardiac catheieriatirm and coronary angiagmphy. 
Patent ofthe infarcbrelatfd vossol was 70% in Grwp 
A, 66% in Group B and 33% in Group C and the awnage 
Tluwnba,ylis in M~wwdlat lnfhrcthm (TIMI) coronary 
prfusk~~ grade was 1.9 * 0.8 for Gmup A, 1.6 2 1.0 for 
Croup B and 0.84 * 0.95 for Gmup C (Glwp A wsus 
Croup C p < 0.01; Gmup B versw Gmup C p < 0.051. A, 
prediscbarge evahmtiw, mean letl ventricular end-systolic 
and eod-diastdic voluws were highor in Group C ,han in 
Evidence is accumulating that intravenous administration of 
thmmbolytic agents early in the cww of myucxdia! infarc- 
tion frequently causes reperfusion in the reversibly inrured 
myocardium. probably limiting infarct size and IeR ve.r,ric- 
ular dysfunction and reducing both early and late morlalily 
(l-7). Thrombolylic therapy of evolving myocardial infarc 
lion is based on the concept that severely ischemic myocw 
.A, 1 ?ear follow-up study, eod.rys,oiic and end-diastolic 
volunws remained higher in Group C ulsn in Group % (p C 
0.05 for both) and Group A tp < Q.@X for end.ayrto%c 
volume and p < O.MII for end&w,olic volume); ejpctirm 
fraction P, rest was lower in Group C &an in Gmups .A and 
% CD < 0.05 for both): dwine ewrcise. it increated more in 
dium can be salvaged by resroring blood supply ,o reversibly 
injured IIPSUC. I, has been demonstrated that ,he earlier 
reoerfuaion is achieved. Ihe more likelv mvocardLii damage 
can be lim+d and mortality reduced a. 
The potential value of the late administration of throm- 
bolylic therapy in patients with acu,e myocardial infarction 
is hiehlv comroversial. In the Second International Stud) of 
I, 
Infarct Survival (ISIS-2) (9). a reduced mortalily rate was 
observed a, 5 weeks, even when lherapy *as begun 12 10 ?4 
h af,cr the onse, of symptoms. There is also evidence fhat 
la,e coronary thrombolysis may improve survival no, by 
reducing infarct size, but by improving electrical stability of 
the hear, (101 or by acting beneficially on myocardial rem& 
ehng after mfarction (I I ,IZ). The possibility that reperfusion 
can favorablv influence myocardial infarct healin& regard- 
less of its &et on my&dial salvage, has important 
imolications for the firnine: of treatment and the size of the 
pa&t pool likely to benefit fmm rcpetfusion (13). 
The purpose of this study was to evaluate the potential 
value ofdelayed tbrornbolysis on left ventricular functmn in 
acute myvcardial infarction. We erz!aated left ventricular 
end-systolic and end-diastolic volumes. ejection fraction and 
global.ball motion index in patients with acote myocardial 
infarction watcd with thrombolytic agents between 4 to S h 
after the onset of symptoms and cornpared these data witi, 
data from untreated paoents and fam patients treated within 
4 h of acute infarction. 
Methods 
Study patients. Seventy-six patients <70 years of ag 
were admitted to our coronary c&e unit betwe& March and 
November 1988 within 8 h from the onset of chest oain and 
with electrocardiographic (ECG) signs suggestive bf acute 
anterior myocardial infarction. Eighteen patients were ex- 
cluded fmm the study because of I) history of previous 
myocardial infarction: 2) any major hemorrhage or *woke 
during the preceding 6 months; 3) major i&y or surgery 
during the preceding 6 weeks: 4) adtopulmonary resusci- 
tation per&rraed on aamission to hospital; 5) severe arterial 
hypertension (systolic blood press& 2220 mm Hg); 6) 
known bleeding disorder; 7) active peptic ulcer; 8) possibility 
of pregnancy: ,‘r 9) proliferative diabetic retinopathy. 
A rota1 of5dporienrs were digibkfor the rrial. The study 
protocol was approved by the institulional committee on 
human research and all patients 8ave informed consent. of 
the patients enrolled, I8 were admitted within 4 h of the 
owe! of chest pain (Group A) and were treated with single 
chain recombinant issue-type plasminogen activa:or trt.PA) 
given intravenously at adose of 100 mgover3 h (IO m&b&s 
injection followed by an infusion of 50 mg over I h and then 
20 m@‘h over the next 2 h). The remaining 40 patients were 
admitted 4 to 8 h after symptom onset and were randomly 
assigned to one of two groups: Group B, 20 palients who 
received xl-PA on the same dose schedule as Grouo A. and 
Group C. 20 patients given conventional therapy: All pa- 
tients were provided with the usual coronary care practice. 
Blood was sampled for serum crcatmc kinase immdiately 
after admission. every 3 to 6 h over the next 24 h and then 
every I2 to 24 h over the next 48 h. Standard electroeardio- 
grams (Et?.&) wrc recorded at regular intervals and con- 
sinuous ECG monitoring was performed throughout the 
recovers wcriod in the comnarv care unit. 
All &up A and B paticms’received a bolus injection of 
5.@30 IU of heparin. followed bv infusion of I.000 U/h of 
heparin begun i h after the bolus (njcctionand the startofthe 
II-PA infusion. The heparin dose was adjusted to keep the 
level of partial activated thromboplastin time between I.5 
and 2 times the upper limit & noiinal. Heparin was contin- 
ued in absence of serious hemorrhage until 7 to 10 days after 
the onset oftherapy when predischarge cardiac catheteriza- 
tion was performed. Heparin administration was also pcr- 
formed in the same manner in Group C patients not treated 
with r&PA. Just before hepain administmtion was stopped, 
treatment with 75 mg of dipyridamole three times daily and 
325 mg of aspirin daily was begun and continued for at least 
I year. 
Rerween 7 and 10 days afrer odndmioa. all patients 
underwent tight and left hean catheterization, coronary 
angiography, echocardiography and radionuclide angiogn- 
phy. 
Coronary perfusion was evaluared according to the 
Thrambol+ in Myoardial Infarction (TIMI) Phase I Trial 
grading scale (14). The infarct-related artery was defined by 
the location of I) ST segment elevation on the ECG: 2) 
hypokinetic wall motion on the ventriculogram: and 3) 
residual stenosis or thmmbatic material. or both. in the 
coronaty amy. 
E;imcardicgmphic pmtaml. Two-dimensional echocar- 
diographic examination was performed in the hospital by 
means of a Bioaound 2600 ND eehocardioeraoh with we of 
parastcmal. apical and subcostal views.‘L&t ventricular 
end-diastolic and end-systolic volumes were computed ae- 
cording to an algorithm that related left ventricular volume 
to a h&cilipsoid and half-cylinder geometry (IS). An apical 
four chamber ventricular long-axis view and perpendicular 
mid-ventricular septum to lateral wall distance were used. 
assuming a circular left ventricular cross-sectional contig- 
w&ion. Enddiastole was defined as the frame coincident 
with the onset of the 3RS corn&x on the ECG and 
end-systols as the subseq&t i&c with Ihe smallest ven- 
tricular cavity area. All volumes were normalized to body 
surface area. calculated from height and weight measured 
immediately before each study (16). Wall motion was cval- 
uated in I I segments of a left ventricular model as proposed 
by Edwards et al. (17) and modified to consider the apex as 
a single agment. Studies were considered adequate for 
analysis only when each of these I I segments was included 
in at least one view. Wall motion in each segment wasgraded 
on a scale of I to 4 (I = nomml, 2 = hypokinetic. 3 = 
akinctic and 4 = dyskinetic) (18). To assess global left 
ventricular function, a gloh?l wall motion index was calcu- 
lated by summing the seor~s for each segment and dividing 
by the number of scemcnts analvzcd. 
The examinations, stored on videotape, were reviewed 
and analyzed by the staff of the echocardiographic labora- 
tory. Two observers unaware of each other’s interpretation 
and without advance knowledge of the patient’s clinical data 
performed quantitalive and s&dqoan&tivc analysis of re- 
corded images. Concordance of analysis was achieved in 
95% of eases. Ii discrepancies arose. these studies were 
reviewed and agreement was obtained. 
Radionuctidc mgiography. High :crnporal xwlution 
mdionuclidc rmgiognphy wa, performed with the paucnt %br 
rest in the rupine positron. Red blood cells were labeled m 
viva with 25 mCi of technetium-YYm lmagmg wx pcr- 
formed wdh a small field of view Anger cxnem equipped 
with a low energy, general purpose. parallel hole ctllunzator 
oriented in the 45” left anterror obhquc povtmn. wnh d IS 
caudal tdt. Data were acquired in frame mode by curnputcr- 
based ECG gating. with 2x digital LOOI. The unugmg rat 
was LO msifrnme (that is. 50 framesl?l: l~O.iUXl counts/frame 
were collected. Ejection fraction wx measured on the raw 
time-activity curve by ? -!?ndnrd technique and cxprcrsed rn 
percent (19). 
EAm7rdio~raphir. und mdkmrr~l~dr .mdicr wow w 
peafed approximately I year after the mniid isve~tigetmn~ 
trange 320 to 412 days). The mdionuchde study wx carried 
out under baseline conditions a> already dexribed. t?rticnrr 
were then instructed on the nelcctcd ~xercrse protocol ,tnd 
petfoned a symptom-limated supine bicycle stress test. 
Exercise stages were 3 min in duration. with work turds set 
at progressively increasing 25 W mcrements. Data for cal- 
culating ejection fraction were obtained during the last 2 min 
of each exercise stage. 
Study gmups. Of the 58 patients enrolled. 24 (41 .&I 
were not included in the final armlysia (7 112%1 with inadc- 
quate quality of echocardiographic images I3 in Group A. 2 
in Group B and 2 in Group Cl. 3 [5.2%1 with atrial fibrillation 
[I in each group]. I [1.7%1 with an unconfirmed diagnosra of 
myocardial infarction [Group Al, 2 13.4%1 with new cow. 
nary wcnts II in Group A and I in Group BI. 5 [8.7%1 wi:h 
in-hospital death [I tn Group A. 2 in Group Band 2 in Group 
Cl. 4 [&%I with death during the follow-up period II in 
Group A, I in Group B and 2 io Group Cl and 2 13.4?V lw 
duringthefollow~upperiod II inGroupBand I ioGrowC1,. 
Echccardiographic and radionuclide data were therefore 
available and analyzed for this study in 34 palienls: of these. 
IO were in Group A I8 men and 2 women. mean age 54.5 2 
11.6 year% !? in Gmup B !C men xx! :xom;a. iilL‘l#l <d&z 
56.3 ? 9.9 wars) sod I? iu Zroun C 1 IO men and 2 women. 
mean age 57.2 -_ 9.4 years,. 
Cwdiowswhr ntedicstions wre wmpnrnhly ared irr rhr 
rlrrer prorrps. In particular. beta-adrenergic blocking agent? 
were administered in three Group A, two Group Band two 
Group C patients: calcium channel antagonists were used in 
one Group A, one Group B and one Group C patient. 
Angiotensin-convening enzyme inhibitors were used on the 
basis of clinical signs of heart fadure in two Group A. two 
Group B and three Group C patients only after the predis- 
charge echocardiographic and radronuclide x&graphic 
data acquisition. No patient had high blood oressure valucc 
that required antihypertensive medicalron. 
Statistical analysis. All !he results are expressed as mean 
values ? amdard deviation. One-say analysis of variance 
~1s wed for statistical evaluatron: if a significant Ip < 0.05) 
F tat wa\ found. Student.5 I tc~t for “npaircd ohwrwrwn 
irllh Ihc Bonferroni correction was used for multiple com- 
parr\on\. Contutgcncy table analy\is was pcrformcd for 
c:ncgorrc:d v:uiahlc* A puircd I :SFI wx performed to 
cwIwtc data ohtsined in the wnc group at pwdrdlrchargc arid 
at the snd of the follow-up \,“dy. 
aesults 
Time of thrombolytic therapy and serum rr~sline kinw. 
Pntrcnl\ m ihc three groups were comparable in ferrw of age. 
gender. event of coronary artery diveat and hemodynamic 
\arrahle\. Tbc man txnc of intervcntmn was 159 * 48 min 
m Group :A. 138 = 61 min m Group B and 344 c 6; min P 
tiroup C. The peak \erum creatmr kmaie value a$pzared 
\igniticantlv curlier in Group A ($0 f 4 hl than m Croup\ B 
, I4 -L 4 h) .Ind C (20 + 6 h) (Group A verw~ Group B p -: 
ll.Oi, Group A verws Group C p < 0.011. Peak wrum 
c:eidm~ kinae wlws were 3.925 ? 2.230 mU’ml in Group 
A. 3.6SR f l.SO5 rntifmr in Group B dnd 2.55R 2 934 mU/ml 
in Group C Ip = NS for all). 
TIM1 perfuskm grade. At the lrme of coronary angrogra- 
yhy. pauncy of the mfwcr-related vessel evaluated us TIM1 
grade 2 or 3 was found m 7 170%) of IO patrents in Group A. 
8 If&ii of I? in Group Band 4 (33%) of I? in Group C: the 
werage Tlhll grade was 1.9 2 O.Sfor Group A. 1.6 2 I.tlfor 
Group B and 0.84 +_ 0.95 for tiroup C (Group A vercus 
Group B p = NS; Group A versus Group C p < 0.01: Group 
B vc;au\(iroup C p <b.O5,. 
Rrdirrharge eehocardiographic and radionuclide data 
(Tables I to 3). At predischag? study. echocard;Q&raphic 
mean left ventricular end-systolic volume was higher in 
Group C than in Groups B (p < 0.031) and A (p < O.M)5): 
mean left ventricular end-dwtolic volume was also higher in 
Group C than tn Groups B Ip c O,OS) and A lp < O.OOS>. No 
ditTerence: were detected in left ventricular end-diastolic 
and end+ystolic volume5 hrrwvrrn O:c-;: .Z ;r.z? 8. 1Z.u 
icit ventncularejection fraction at rest wab lower in Group C 
rhan in Groups Band A (p < 0.05 for both). 
One gear follow-up data. Mean left ventricular end- 
systolic volume remained higher in Group C than in Groups 
B (p < 0.05) and A tp < 0.005). Mean leit ventricular 
end-diastolic volume was alto higher in Group C than il: 
Group\ 6 ,p < 0.05) and A Ip < O.MIIL As observed I 
predrxharge stud). ejectron fraction at reel was lower in 
Group C than in Groups B and A (p < 0.05 for both, and 
increaxd more during exercise in Group A than in Group C 
tp < 0.011: no differences in the increase were observable 
between Groups A and B or betueen Groups B and C. 
Globel wall motion index values were comparable in the 
three study groups. both at predischarge and at follow-up 
cxaminatuxts. 
low-up ewl~mrion. a statistical difference was detectable in 
Group C patients for end-systolic and end-diastolic volumes 
(p < 0.05 and p < 0.091, respectively) and in Group B for 
end-diastolic volume tp < 0.05). 
Our study was focused on two unresolved questions 
about tbrombolysis: whether late thrombolysis is effective in 
preserving left ventricular function and. if so, by what 
mechanism. Our results support the hypothesis that the 
administration of rt-PA either early or late in patients with 
acute myocardial infarction lessens postinfarclion left ven- 
tricular dilation. avoiding infarct expansion. 
infarct expansion. Myocardial expansion has been ob- 
served within the first few days afler acute myocardial 
infarction (20-221, reaching a plateau at I week (23) and 
continuing over a period of 6 to 30 months (24). Myocardial 
able 2. Croup B: Echocardiographic and Radionucllde 
Angiograpbc Data From 12 Patients With Anterior Acute 
Mjocnrdial tnfarction Treated Wtth Late Thrombolyra 
1 to 8 h After Onset of Symploms 
expansion is accompanied by a regional deformation of 
ventricular shape and a marked abttomtality of the infarct- 
related segment, leading to a significant increase in left 
venlricular cavity size. McKay et al. (25) developed B model 
of left ventricular remodeling aher acute myocardial iniarc- 
don. In this model. acute infarction induces left ventricular 
systolic and diastolic dysfunction, leading to an increase in 
systolic and diastolic wall stress in both infarcted and 
noninfarcted segments. In the infarcted segments. dilation 
and lhinning pragress until the healing of injured myocw 
dium increases the ability ofthe zone to resist wall stress. In 
noninfarcted segments, diastolic stress provides the stimulus 
for volume overload hypertmphy that tends 10 return sys- 
tolic and diastolic wall stress toward nomml. These remod- 
eling changes that occur i* some patients after acute myo- 
cardial infarction result in an increase in left ventricular 
volume and seem to bc associated with hemodyttamic im- 
provetnent, including lower left ventricular filling pressure 
and increased cardiac output. Nevertheless. myocardial 
expansion is deleterious; studies in humans and animals 
have demonstrated that infarct expansion is the morphologic 
substrate for aneurysm fomtation (26) and early cardiac 
dilation (27). A two-dimensional echocardiographic fol- 
low-up study (24) suggests an overall progressive cardiac 
dilation involving remote myocardium as a late consequence 
of early regional infarct expansion. Currently. left ventrtcu- 
lar dilation is thought to be a consequence of infarct expan- 
sion rather than a compensatory mechanism. 
Lell venlricuku voiume. Kostuk et al. (28) observed an 
increased morbidity and mortality in postinfarction pattents 
with increased left ventricular stze and White et al. (29) 
demonstrated that en2 systolic volume is the most signiii. 
cant predictive factor of prognosis in patients with myocar- 
dial infarction. Therefore, it appearc that studtes are needed 
In tht\ regard. Pfcffcr er al. 130.31) Thawed that adminis- 
wataon of captopril to reduce left ventricular ?y~toItc wall 
\trf\\ iewl:\ m lew ventncular dilation and prolonged 
wrv~v~l m rats with experimentally induced myocardml 
mfarcraon. Furthermore. ~apl~pril has indwed hemody- 
nxmc unprovement and diminished the degree of remodel- 
ing !n patvxts with acute infarction and severe left ventnc- 
alar dysfunction 132). 
Invc~iigations performed to ammal models tIl.12) and 
preliminary clinical studies 03.34) offer evidence of benefit 
horn rcpetiusion independent of myocardial salvage. It has 
illso been demonstrated (35-37) that rcpcrfus~on Qraducec 
cdem:t. hemorrhapc and myocardial contractore: thus. in- 
farcted myncardium is stiffer and more likely to resist 
intrarentricular pressure. leading to reduced infarct expan- 
sion and aneurysm fomxation. 
fhrombolysis and eRect an left ventricL>.r function. Most 
recent trials assessing the effect of thmmbolytic agents on 
left ventricular function have focused on ejection fraction: 
the eRecta of thrombolysis on left ventricular volume after 
acute myocardial mfarctian have rarely been reported. The 
rerults of the recent two-dimensional echocardiographic 
project of the Gruppo ltaliano per lo Studio della Streptochi- 
nasi nell‘lnfarto Miacardico (GISSU (38) support the hy- 
pothests that strcptokinase improves left ventricular remad- 
cling and function in patiec!: wi:b myocardial infarction. 
reduciop. the extent of regiooal wall motion abnormalities 
and lesszning postinfarction left ventricular dilation. but the 
results of this study are somewhat intriguing. In fact. differ- 
ences in volumes and regional wall motion abnomnlilies 
between streptokiwse-treated and control patients were 
significant only for patients enrolled between 3 and 6 h ailer 
the onset of symptoms. The wend was clear but not signili- 
cant for patients ec:o!!ed after 6 h and much less clear for 
patients enrolled within 3 h of symptom onset. One proposed 
W.QlanahI is that the restraining effect of the drug on infarct 
expansion and volume increase is more marked after later 
infwion. Against this interpretation are the results of other 
trials (39.40) in which patients treated before 3 h benefit 
more as assessed by angiographically determined ejection 
fraction. It must be considered, however, that the GISSI 
tnal was a multicenterechocardiographic study performed in 
patients with myocardial infarction utilizing streptokinase as 
a thrombolytic agent. In another study, Warren et al. (41) 
found that relatively late thrombolysis (5 f 1 h) in :he course 
of acute myocardidial infarction did not prevent subsequent 
development of left ventricular dilation, most probably be- 
cause of delayed intervention. However, Warren et al. (41) 
studied patients treated with different thrombolytic agents 
administered by either the iotraco;onary or the intravenous 
route; moreover, left ventricular volumes were obtained by 
radionuclide rmgiography on the basis of a planimetric 
method and geometric assumptions. 
r&PA versus streptoktnase. In our study, we administered 
the thrombalytic agent R-PA in patients with anterior myo- 
cardial infarction because it has been shown to have greater 
thrombolytic efficacy than streptokinase: thus, the patency 
rate of the infarct-related vessel is significantly higher with 
R-PA than with streptokinase whether or not patients are 
treated within 4 h of symptom onset (42). Reocclusion of the 
infarct-related atety OCCUR more frequently with n-PA than 
with streptokinase and can he only partially prevented with 
heparin or by mainlaining rt-PA infusion (43,441. Currently, 
r&PA is used extensively in patients with myocardial infarc- 
tion; therefore, studies are needed to investigate the effects 
of this thromholytic agent on left ventricular volume and 
function. The limitation of the study in patients with anterior 
myocardial infarction was based on tile observation that 
patients at risk for infarct expansionarepredominantly those 
with a large anterior or anteroseptal tr”nsmuraI infarction 
(25,411. 
Rate al reperfusian of the infarct-related artery. In our 
study, patients treated between 4 and 8 h after the onset of 
symptoms with conventional therapy showei higher left 
ventricular end-systolic and end-diastolic volumes than pa- 
tients treated with R-PA. No difference was observed in left 
ventricular end-systolic and end-diastolic volumes between 
patients treated with n-PA within 4 h or after. Furthermore. 
mean ejection fraction was lower in Group C than in Groups 
A and B and, at I year follow-up study. ejection fraction 
during effotl increased less in patients in Group C than in 
those in Groups A and 8. The mechanisms underlying these 
beneficial effects of thrombolysis are uncertain. but the 
reopening of the infarct-related wtery seems to play a 
primary role. In fact, in our patients, reopening of the 
infarct-related artery was observed in 70% of Group A, 6.5% 
of Group B but only 33% of Grow C oatients. These findines 
are in agreement 4th those of Jirem) et al. (45), who noted 
an increase in left ventricular end-diastolic volume in all 
patients without spontaneous reperfusion of the infarct- 
related anery. and only very rarely in patients with sponta- 
neow reperfusion. Other investigators (46,47) have also 
observed that spontaneous reperfusion of the infarct-related 
artery was associated with improved lefl ventricular func- 
tion. Furthermore, Verheught et al. (48) reported that left 
ventricular ejection fraction measured by radionuclide angi- 
ograpby increased in patiemr with and decreased in patients 
without spontaneous repelfusion. 
Mean global wall motion index was lower in Group A 
patients, even though the differences were not statistically 
significant. This finding may be r&cd to a reduction in the 
extent of myocardial infarction in the early thrombolysis 
group and the lack of a significant difference may he the 
consequence of the difficulties in assessing the endocardial 
wall motion score in patients with myocardial infarction (49). 
Delayed beneficial effects. At t year, there was a further 
increase in left ventricular end-systolic volume only in 
patients not given n-PA; therefore, the early beneficial 
effects obtained with thrombolytic agents persist for at least 
1 year. Left ventricular dilation after acute myocardial 
infarction is progressive and even thouah it oeaks in the first 
days. the process continues for 6 td I2 months. Similar 
observations have been made in a recent clinical study (45). 
The fact that there was no change in ejection fraction in 
Group C after t year despite left ventricular dilation is not 
surprising: Gadsboll et al. (50) used a radionuclide method to 
study patients with acute myocardial infarction before dis- 
charge and t war later and found an increase in left 
vent&&u end-systolic and end-diastolic indexes but no 
signiticant change in ejection fraction. 
Differences in cardiovascular drug administration cannot 
account for the observed results because in our study all 
cardiovascular medications were used comparably in the 
three groups. In particular. angiotensin-converting enzyme 
inhibitor therapy administered in two Group A, two Group B 
and three Group C patients was started only after predis- 
charge data acquisition on the basis of clinical signs of heart 
failure. 
Concluriollr. Our results support the efficacy of late 
thrombolysis in patients with acute myacardial infarction 
and suggest that drugs acting on left ventricular remodeling 
should he recommended in patients with anterior myocardial 
infarction who more frequently exhibit infarct expansion. In 
fact. the favorable effect on left ventricular function oh- 
served even with late thrombolysis seems to be related to a 
reduction in myocardial expansion and dilation. 
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